¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Á¦22Â÷ Çмú´ëȸ : 2022-10-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Á¦22Â÷ Çмú´ëȸ : 2022-10-02
±³À°ÀÏÀÚ : 2022-10-02
±³À°Àå¼Ò : ¾Ú¹è¼­´õ ¼­¿ï Ç®¸¸ È£ÅÚ ±×·£µåº¼·ë 2F  
±³À°ÁÖÁ¦ : 2022 ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Á¦22Â÷ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ  
´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674  
À̸ÞÀÏ : gschoi@humming.co.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í Á¤È¸¿ø4¸¸¿ø,Æò»ýȸ¿ø2¸¸¿ø,Àü°øÀÇ1¸¸¿ø,ºñȸ¿ø20¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 09:30~09:40 Antipruritic effect of synthetic TRPM8 channel agonist (cryosim-1) gel on histaminergic and non-histaminergic itch in healthy human skin: a single-blind, randomized vehicle-controlled study  À̼ҿ¬(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 09:40~09:50 Long-Term Efficacy of Dupilumab in South Korean Adults With Moderate-to-Severe Atopic Dermatitis: Results From an Open-Label Extension Trial  ³ëÀ±Áø(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 09:50~10:00 Interferon-¥ã inducible protein 10 promotes Th2 inflammation by activating IL-4-secreting Th2 cells, exacerbating mite allergen-sensitized atopic dermatitis  ¹æÁø¼±(°æºÏÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 10:00~10:10 ASSOCIATION BETWEEN METABOLIC SYNDROME AND ATOPIC DISEASES INCLUDING ATOPIC DERMATITIS, ALLERGIC RHINITIS AND ASTHMA  ±Ç¹ÎÁ¤(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 10:10~10:35 Interpretations of research data for atopic dermatitis  ÀÌ¿µº¹(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 10:35~11:00 Practical laboratory tests in your clinic  ÇÑÅ¿µ(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 11:00~11:20 What's new in researches of atopic dermatitis?  À̵¿ÈÆ(¼­¿ïÀÇ´ë) 
È޽Ġ10-02 ±×·£µåº¼·ë 11:20~11:40 Break time  () 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 11:40~12:20 Recognizing the multi-dimensional impact of atopic dermatitis patients and systemic comorbidities  Jonathan Silverberg(George Washington University School of Medicine and Health Sciences, USA) 
½Ä»ç 10-02 ±×·£µåº¼·ë 12:20~13:10   () 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 13:10~13:20 Mycosis fungoides Found in Patients with Atopic Dermatitis Refractory to Dupilumab  ±¹Çüµ·(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 13:20~13:30 New On of Alcohol Flushing in Patients with Atopic Dermatitis Treated with Dupilumab: Is It an Underrecognized Adverse Event?  ½Éµ¿Çö(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 13:30~13:40 Preventive effects of topical diquafosol on dupilumab-associated conjunctivitis in atopic dermatitis: an open-label prospective study  ÀÌÁø¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 13:40~13:50 Effects of Gamma-Linolenic Acid Adjuvant Therapy in Patients with Atopic Dermatitis: A Survey Study  µµÁöÀ±(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 13:50~14:30 Optimal use of Janus kinase inhibitors and dupilumab for atopic dermatitis based on the current evidence  Masahiro Kamata(Teikyo University, Japan) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 14:30~14:55 Update in pediatric atopic dermatitis  Àå¿ëÇö(°æºÏÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 14:55~15:20 Treatments of pediatric atopic dermatitis : Face to unmet needs  °íÇöâ(ºÎ»êÀÇ´ë) 
È޽Ġ10-02 ±×·£µåº¼·ë 15:20~15:40 Break time  () 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 15:40~16:20 Treat to target in atopic dermatitis : Significance and strategy  Yoko Kataoka(Osaka Habikino Medical Center, Japan) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 16:20~16:45 Biologics & small molecules treatment of atopic dermatitis patients : How and when?  ½Å¹Î°æ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 10-02 ±×·£µåº¼·ë 16:45~17:10 Upcoming therapies of atopic dermatitis compared with psoriasis : What's in the pipeline?  ¹èÀ¯ÀÎ(ÇѸ²ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Á¦22Â÷ Çмú´ëȸ : 2022-10-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ÀÏÂ÷ÀÇ·á±â°ü °¨¿°º´ ´ëÀÀ ¿Â¶óÀÎ ¿¬¼ö±³À°(Á¦4Â÷) : 2022-10-04
´ÙÀ½±Û ´ëÇÑÅëÁõÇÐȸ ºÎ¿ï°æÁöȸ Áý´ãȸ : 2022-10-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
482 ºÎ»ê ºÎ»ê±¤¿ª½ÃÀÇ»çȸ ¼­±¸ÀÇ»çȸ 9¿ù Çмúȸ : 2018-09-05 0 636 2018-08-22
481 ´ë±¸ 2018³â ´ëÇÑ°¨¿°ÇÐȸ ¿µ³²Áöȸ 9¿ù Áý´ãȸ : 2018-09-05 0 476 2018-08-22
480 ´ë±¸ ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ´ë±¸°æºÏÁöȸ Çмúȸ : 2018-09-04 0 710 2018-08-22
479 ¼­¿ï ¼­¿ïƯº°½Ã¸³ º¸¶ó¸Åº´¿ø ¼­³²Áö¿ª À̺ñÀÎÈÄ°ú °³¿øÀÇ Áý´ãȸ : 2018-09-04 0 667 2018-08-22
478 ÀÎõ Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-03 0 796 2018-08-22
477 ºÎ»ê ºÎ»ê´ëÇб³º´¿ø ÇǺΰúÇÐÀÇ ÃÖ½ÅÁö°ß : 2018-09-03 0 979 2018-08-22
476 ¼­¿ï Á¦3ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ³»½Ã°æ±â±â/½ºÅÙÆ®¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-02 0 604 2018-08-22
475 ¼­¿ï ´ëÇÑÀ§´ëÀå³»½Ã°æÇÐȸ Á¦32ȸ Ãß°èÇмú´ëȸ : 2018-09-02 0 1,817 2018-08-22
474 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ [KIDEC]Korea International Digestive Endoscopy Congress for Globalization of IDEN : 2018-09-02 0 1,697 2018-08-22
473 ´ëÀü À»Áö´ëÇк´¿ø 2018³â Á¦1Â÷ ´ëÇѽºÆ÷Ã÷ÅëÁõ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2018-09-02 0 1,387 2018-08-22
472 ¼­¿ï Á¦2ȸ Interactive Vascular Diagnosis and Treatment : 2018-09-02 0 497 2018-08-22
471 ºÎ»ê Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-01 0 487 2018-08-22
470 °­¿ø ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ °­¿øÁöȸ Çмúȸ : 2018-09-01 0 488 2018-08-22
469 ¿ï»ê ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦3Â÷ Á¤±âÇмú´ëȸ : 2018-09-01 0 1,086 2018-08-22
468 ºÎ»ê ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø ´ëÇÑÅëÁõÇÐȸ ºÎ¿ï°æÁöȸ Çмú´ëȸ : 2018-09-01 0 692 2018-08-22
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷